Pascal and Francis Bibliographic Databases

Help

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23861057

Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine

Author
LESEM, Michael D1 ; TRAN-JOHNSON, Tram K2 ; RIESENBERG, Robert A3 ; FEIFEL, David4 ; ALLEN, Michael H5 ; FISHMAN, Robert6 ; SPYKER, Daniel A6 ; KEHNE, John H7 ; CASSELLA, James V8
[1] Claghorn-Lesem Research Clinic Ltd, Houston, Texas, United States
[2] CNRI-San Diego, San Diego, California, United States
[3] Atlanta Center for Medical Research, Atlanta, Georgia, United States
[4] Department of Psychiatry, University of California, and San Diego Medical Center, San Diego, California, United States
[5] University of Colorado Depression Center, Aurora, Colorado, United States
[6] Alexza Pharmaceuticals, Mountain View, California, United States
[7] Translational Neuropharmacology Consulting, Rockville, Maryland, United States
[8] Alexza Pharmaceuticals, Mountain View, California, United States
Source

British journal of psychiatry (Print). 2011, Vol 198, Num JAN, pp 51-58, 8 p ; ref : 35 ref

CODEN
BJPYAJ
ISSN
0007-1250
Scientific domain
Cognition; Psychology, psychopathology, psychiatry
Publisher
Maney, Leeds
Publication country
United Kingdom
Document type
Article
Language
English
Keyword (fr)
Agitation Aigu Efficacité traitement Essai thérapeutique contrôlé Etude multicentrique Forme pharmaceutique Homme Inhalation Loxapine Neuroleptique Pharmacothérapie Psychotrope Schizophrénie Toxicité Tranquillisant Voie respiratoire Antagoniste Appareil respiratoire Dérivé de la dibenzoxazépine Psychose Récepteur dopaminergique D2 Traitement
Keyword (en)
Agitation Acute Treatment efficiency Controlled therapeutic trial Multicenter study Dosage form Human Inhalation Loxapine Neuroleptic Pharmacotherapy Psychotropic Schizophrenia Toxicity Tranquillizer Respiratory tract Antagonist Respiratory system Dibenzoxazepine derivatives Psychosis D2 Dopamine receptor Treatment
Keyword (es)
Agitación Agudo Eficacia tratamiento Ensayo terapéutico controlado Estudio multicéntrico Forma farmacéutica Hombre Inhalación Loxapina Neuroléptico Farmacoterapia Psicotropo Esquizofrenia Toxicidad Tranquilizante Vía respiratoria Antagonista Aparato respiratorio Dibenzoxazepina derivado Psicosis Receptor dopaminérgico D2 Tratamiento
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02B Neuropharmacology / 002B02B03 Psycholeptics: tranquillizer, neuroleptic.

Francis
770 Psychology. Psychoanalysis. Psychiatry / 770-E Psychopharmacology / 770-E03 Psycholeptics: tranquillizer, neuroleptic…

Discipline
Pharmacological treatments Psychopathology. Psychiatry. Clinical psychology
Origin
Inist-CNRS
Database
FRANCIS ; PASCAL
INIST identifier
23861057

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web